Still, its a good potential customer acquisition strategy for Novo Nordisk, Leventhal said, because its tapping into a retailer that has a very, very loyal and large customer base. Overall, GLP-1s are getting cheaper, he added, because companies like Novo Nordisk and Eli Lilly, which makes GLP-1s Zepbound and Mounjaro, want to compete with the compounding market
Zepbound has FDA-reviewed labeling and manufacturing
Every body reacts differently to tirzepatide
Some people explore additional compounds alongside tirzepatide to address specific issues
The tirzepatide weight loss timeline from clinical research shows progressive weight reduction through week 72, with the steepest losses occurring between weeks 12 and 36
Because of that, and the direct comparison being nonsuperior, the putative placebo analysis should be treated as supportive evidence rather than conclusive proof of cardiovascular protection